US667381A - Xanthin homologue and process of making same. - Google Patents
Xanthin homologue and process of making same. Download PDFInfo
- Publication number
- US667381A US667381A US2403100A US1900024031A US667381A US 667381 A US667381 A US 667381A US 2403100 A US2403100 A US 2403100A US 1900024031 A US1900024031 A US 1900024031A US 667381 A US667381 A US 667381A
- Authority
- US
- United States
- Prior art keywords
- acid
- xanthin
- uric acid
- solution
- boiling
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 title description 40
- 238000000034 method Methods 0.000 title description 16
- 239000000243 solution Substances 0.000 description 29
- 229940116269 uric acid Drugs 0.000 description 29
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 28
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 28
- 238000009835 boiling Methods 0.000 description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 17
- 238000010438 heat treatment Methods 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 14
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 12
- 229910052709 silver Inorganic materials 0.000 description 12
- 239000004332 silver Substances 0.000 description 12
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 10
- 230000015572 biosynthetic process Effects 0.000 description 10
- 150000007524 organic acids Chemical class 0.000 description 10
- 239000000047 product Substances 0.000 description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- 239000003513 alkali Substances 0.000 description 7
- -1 alkyl radical Chemical class 0.000 description 7
- RTAPDZBZLSXHQQ-UHFFFAOYSA-N 8-methyl-3,7-dihydropurine-2,6-dione Chemical compound N1C(=O)NC(=O)C2=C1N=C(C)N2 RTAPDZBZLSXHQQ-UHFFFAOYSA-N 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 6
- 150000007513 acids Chemical class 0.000 description 6
- 229910052799 carbon Inorganic materials 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 229940074355 nitric acid Drugs 0.000 description 6
- 229910017604 nitric acid Inorganic materials 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 238000010992 reflux Methods 0.000 description 6
- 229910021529 ammonia Inorganic materials 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 229910002651 NO3 Inorganic materials 0.000 description 4
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 4
- LCCDINSFSOALJK-UHFFFAOYSA-N 1,3,4-trimethylpurine-2,6-dione Chemical compound O=C1N(C)C(=O)N(C)C2(C)N=CN=C21 LCCDINSFSOALJK-UHFFFAOYSA-N 0.000 description 3
- QFDRTQONISXGJA-UHFFFAOYSA-N 1-methyluric acid Chemical compound O=C1N(C)C(=O)NC2=C1NC(=O)N2 QFDRTQONISXGJA-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 150000001721 carbon Chemical group 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000000155 melt Substances 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 3
- 150000007968 uric acids Chemical class 0.000 description 3
- GMSNIKWWOQHZGF-UHFFFAOYSA-N 3-methyl-9H-xanthine Chemical compound O=C1NC(=O)N(C)C2=C1N=CN2 GMSNIKWWOQHZGF-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 2
- 235000011054 acetic acid Nutrition 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- HIMXGTXNXJYFGB-UHFFFAOYSA-N alloxan Chemical class O=C1NC(=O)C(=O)C(=O)N1 HIMXGTXNXJYFGB-UHFFFAOYSA-N 0.000 description 2
- 150000008064 anhydrides Chemical class 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 2
- LSACYLWPPQLVSM-UHFFFAOYSA-N isobutyric acid anhydride Chemical compound CC(C)C(=O)OC(=O)C(C)C LSACYLWPPQLVSM-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical compound [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 description 2
- LJYRLGOJYKPILZ-UHFFFAOYSA-N murexide Chemical compound [NH4+].N1C(=O)NC(=O)C(N=C2C(NC(=O)NC2=O)=O)=C1[O-] LJYRLGOJYKPILZ-UHFFFAOYSA-N 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 229910001961 silver nitrate Inorganic materials 0.000 description 2
- YHNNPKUFPWLTOP-UHFFFAOYSA-N 7-Methyluric acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2C YHNNPKUFPWLTOP-UHFFFAOYSA-N 0.000 description 1
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical class N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 1
- MNIKDKWDJXTNON-UHFFFAOYSA-N 8-ethyl-3,7-dihydropurine-2,6-dione Chemical compound N1C(=O)NC(=O)C2=C1N=C(CC)N2 MNIKDKWDJXTNON-UHFFFAOYSA-N 0.000 description 1
- ZGCYLVDTYUCUNV-UHFFFAOYSA-N Dimethyluric acid Chemical compound CC12NC(NC1(NC(NC2=O)=O)C)=O ZGCYLVDTYUCUNV-UHFFFAOYSA-N 0.000 description 1
- 206010021703 Indifference Diseases 0.000 description 1
- 125000000066 S-methyl group Chemical group [H]C([H])([H])S* 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 239000010425 asbestos Substances 0.000 description 1
- PRORZGWHZXZQMV-UHFFFAOYSA-N azane;nitric acid Chemical compound N.O[N+]([O-])=O PRORZGWHZXZQMV-UHFFFAOYSA-N 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- SURLGNKAQXKNSP-DBLYXWCISA-N chlorin Chemical compound C\1=C/2\N/C(=C\C3=N/C(=C\C=4NC(/C=C\5/C=CC/1=N/5)=CC=4)/C=C3)/CC\2 SURLGNKAQXKNSP-DBLYXWCISA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- VKJKEPKFPUWCAS-UHFFFAOYSA-M potassium chlorate Chemical compound [K+].[O-]Cl(=O)=O VKJKEPKFPUWCAS-UHFFFAOYSA-M 0.000 description 1
- 235000011118 potassium hydroxide Nutrition 0.000 description 1
- WYVAMUWZEOHJOQ-UHFFFAOYSA-N propionic anhydride Chemical compound CCC(=O)OC(=O)CC WYVAMUWZEOHJOQ-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229910052895 riebeckite Inorganic materials 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
Definitions
- the present invention relates to the art of preparing derivatives of xanthin with special reference to the homologues of this purin, its object being the preparation of homologues in which the hydrogen atom bound to the carbon atom in the position 8 is replaced by an alkyl radical.
- R, R R and R represent alkyl radicals.
- xanthin derivatives have not hitherto been known or produced. I have found in the course of my experiments and researches that such alkylxanthins may be readily prepared by causing an organic acid anhydride to act upon uric acid, such as uric acid proper or its alkyl derivatives. The reaction takes place with the evolution of carbon-dioxid on heating the reagents together under pressure, as well as by boiling in an open vessel combined with a reflux apparatus.
- -3-methyl-uric acid or l-3-dimethyl-uric acid while those uric acids in which the alkyl radical or radicals are bound to the nitrogen atoms occupying the positions 7 or 9 such as 7-methyl-uric acid, 3-9-dimethyluric acid, or 1-3-7 -trimetl1yl-uric acid-are not changed on treating them with acid anhydrides.
- My present invention may therefore be generically expressed by the following general equafinally washed with alcohol.
- the new Xanthin homologues are by the above methods obtained in an almost pure condition, and in general they possess theproperties characteristic of xanthinsviz., complete stability and indifference with respect to ammoniacal silver solutions, the formation of murexid when they are treated with chlorate of potassium and hydrochloric acid,
- This new xanthin is soluble in the usual sol vents only with extreme difficulty. While the solubility of Xanthin in Water is usually considerably increased under the influence of the methyl radical, in the present case the addition of methyl to the carbon atom 8 strongly reduces such solubility. Thus, for example, Xanthin proper requires about fifteen hundred parts of boiling water for complete solution, while 8- methylxanthin requires about three thousand three hundred parts, crystallizing from such solution on slowly cooling the same in the form of colorless short prisms or tablets. S-methylxanthin as a base is soluble with tolerable ease in dilutemineral acids on heating or warming.
- S-methylxanthin has no melting-point. At substantially 380 centigrade it begins to turn brown, and at a temperature above 400 centigrade it is decomposed.
- acetic-acid anhydride or uric acid may be accomplished in a briefer period of time than stated above if the reagents are caused to act upon each other either under pressu ree. g. in a digester-or in the presence of a condensing agent.
- a condensing agent for example, if one part of uric acid proper is heated together with from five to six parts acetic acid in a closed vessel, such as an autoclave, while constantly stirring or agitating the mass, to a temperature of 180 centigrade and maintained; at this temperature for twentyfour hours theconversion into 8-methylxanthin will be completed.
- methylxanthin After cooling a considerable pressure exists in the autoclave, while the methylxanthin will be obtained in the form of a rather brown powder, which may be isolated and purified in the manner above given.
- the same acceleration of the reaction may be obtained when a condensing agent is added to the mixture of uric acid proper and acetic-acid anhydride.
- I may add 0.5 parts of pyridin to one part of uric acid proper and ten parts of acetic anhydride. Under these conditions the formation of S-methylxanthin will have been accomplished after the boiling for from forty to forty-five hours in a reflux apparatus. The new product is thereby obtain ed in a very pure condition and may be isolated in the manner above given.
- methyl-uric acid which is identical with 8 methyl-uric acid, as describede. g., in Berichte der Deuischen Ohemischen Gesellschafl, Vol. 32,page 2726is heated to ebullition with ten parts of acetic-acid anhydride in a reflux cooler and with the addition of 0.5 parts pyridin.
- the conversion into the corresponding xanthin takes place without apparent solution of the methyl-uric acid. After the lapse of about forty hours continued boiling the difficultly-solubleproduct ceases to red uce ammoniacal silver solution.
- 3-8-dimethylxanthin is readily soluble in dilute alkalies, including ammonia.
- concentrated soda-lye NaHO solution
- a sodium salt of the same which crystallizes in fine needles, is soon separated from the whole.
- Dilute mineral acids readily take.
- 3-8-dimethylxanthin assumes a brownish color on being heated to above 320 centigrade, and at about 350 centi grade it melts with decomposition.
- This new trimethylxanthin is soluble in about forty parts of boiling water.
- the solubility of 1-3- dimethylxanthin which is the same as theophyllin and which requires only eight parts of water for solution, (see Bert'chie, Vol. 28, page 3189,) has been very materially reduced by the S-methyl.
- 1-3-8-trimethylxanthin is rather soluble in boiling alcohol and moderately so in boiling chloroform.
- ammonia and dilute alkalies From concentrated alkali solutions the corresponding alkali salts are immediately thrown out in the form of fine acicular crystals. It is readily soluble in dilute mineral acids.
- nitrate of silver in nitric-acid solution a double salt, crystallizing in fine needles, is formed.
- An ammoniacal solution of the same forms with nitrate of silver a silver salt, which is very difficultly soluble in ammonia and which is perfectly stable when boiling.
- 1-3-8-trimethylxanthin melts to a pale-colored liquid at 325 centigrade and sublimes almost without decomposition when continuously heated to a higher temperature in the form of fine colorless needles.
- S-ethylxanthin on being heated above 350 centigrade assumes a brownish color, and at about 390 centigrade it is decomposed with effervescence or frothing.
- 8-alkylxanthin whose formula differs from that of Xanthin proper by having an alkyl radical substituted for the H in the position 8, which is readily soluble in alkalies including ammonia, and in dilute acids and difficultly soluble in boiling water, which is precipitated from the alkaline solution by dilute acids in the form of a granular powder, which becomes colored on heating to a high .temperature and which has no melting-point but decomposes wit-h frothing on heating to a still higher temperature.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
NITED STATES PATENT rrrcs.
FRITZ ACE, OF MANNHEIM, GERMANY, ASSIGNOR TO 0. F. BOEHRINGER 82 SOEHNE, OF WALDHOF, GERMANY.
XANTHIN HOMOLOGUE AND PROCESS OF MAKING SAME.
SPECIFICATION forming part of Letters Patent No. 667,381, dated February 5, 1901.
Application filed July 18, 1900. Serial No. 24,03l. (No specimens.)
To all whom it may concern.-
Be it known that I, FRITZ AOH, a citizen of the Empire of Germany, residing at Mannheim, in the Empire of Germany, have invented certain new and useful Improvements in the Art of Preparing Homologues of Xanthin; and I do hereby declare the following to be a full, clear, and exact description of the invention, such as will enable others skilled in the art to which it appertains to make and use the same.
The present invention relates to the art of preparing derivatives of xanthin with special reference to the homologues of this purin, its object being the preparation of homologues in which the hydrogen atom bound to the carbon atom in the position 8 is replaced by an alkyl radical.
The structural formula of xanthin is:
The general formula of these homologues would be:
or the like, where R, R R and R represent alkyl radicals. These xanthin derivatives have not hitherto been known or produced. I have found in the course of my experiments and researches that such alkylxanthins may be readily prepared by causing an organic acid anhydride to act upon uric acid, such as uric acid proper or its alkyl derivatives. The reaction takes place with the evolution of carbon-dioxid on heating the reagents together under pressure, as well as by boiling in an open vessel combined with a reflux apparatus. This conversion of the uric acid into the corresponding 8 alkylxanthin takes place in most cases apparently without the formation of a solution, and it is completed when a sample of the separated product of the reaction will no longer reduce an ammoniacal silver solution after thoroughly boiling the two together. This new process renders it possible for the first time to proceed directly and in one operation from the uric-acid series to the xanthin series.
According to experiments and observations hitherto made the uric acids which are susceptible to the above reaction are uric acid proper and the derivatives of the same, in which the alkyl radical or radicals are bound to the alloxan nucleus-such, for example, as
-3-methyl-uric acid or l-3-dimethyl-uric acidwhile those uric acids in which the alkyl radical or radicals are bound to the nitrogen atoms occupying the positions 7 or 9such as 7-methyl-uric acid, 3-9-dimethyluric acid, or 1-3-7 -trimetl1yl-uric acid-are not changed on treating them with acid anhydrides. My present invention may therefore be generically expressed by the following general equafinally washed with alcohol.
,The new Xanthin homologues are by the above methods obtained in an almost pure condition, and in general they possess theproperties characteristic of xanthinsviz., complete stability and indifference with respect to ammoniacal silver solutions, the formation of murexid when they are treated with chlorate of potassium and hydrochloric acid,
and the formation of a yellow residue when evaporated together with concentrated nitric acid.
In order to enable those skilled in the art to practice my invention, I will now describe the same in detail with the aid of several ex: amples constituting the preferred embodiment of the same. The proportions are all given by weight.
1. Preparation of 8-mcthylaoanthin from uric acid proper-One part of uric acid proper is boiled, together with ten parts of acetic-acid anhydride, in a reflux apparatus. Carbon-dioxid is very soon liberated steadily, while at the same time the uric acid is converted into S-methylxanthin without going into solution. The conversion is complete after the lapse of about eighty hours continued boiling. To ascertain whether this condition has taken place, the slightly-yellowish brown product, which is insoluble in the anhydride, is tested with ammoniacal silver solution. If the latter ceases to be reduced by the product, the process has been-completed. The whole is now allowed to cool and is then drained by siphoning or by other means and From seventyv five to eighty per cent. of the theoretical The reaction of its formation, as described above, proceeds according to the equationi HNOO coon l l H l 00 O-N +0 co I l HNON coon,
(Uric acid.) (Acetic anhydride.)
(8-methylxanthin.) (Acetic acid.)
This new xanthin is soluble in the usual sol vents only with extreme difficulty. While the solubility of Xanthin in Water is usually considerably increased under the influence of the methyl radical, in the present case the addition of methyl to the carbon atom 8 strongly reduces such solubility. Thus, for example, Xanthin proper requires about fifteen hundred parts of boiling water for complete solution, while 8- methylxanthin requires about three thousand three hundred parts, crystallizing from such solution on slowly cooling the same in the form of colorless short prisms or tablets. S-methylxanthin as a base is soluble with tolerable ease in dilutemineral acids on heating or warming. When dissolved in concentrated hydrochloric acid and allowed to cool, a hydrochlorate of the same is thrown out in the form of colorless shining prismatic crystals, which hydrochlorate, however, gives up its hydrochloric acid on being treated with water. From a solution in concentrated sulfuric acid the 8- methylXanthin, like Xanthin proper, is not precipitated by water. It is readily soluble in alkalies and ammonia. On adding to a solution of the same in ammonia nitrate of silver a gelatinous colorless silver salt is precipitated, which remains unchanged on boiling. From a solution of the S-methylxanthin in nitric acid a flaky double salt is thrown out by nitrate of silver. On treating the 8- methylxanthin with chlorin Water murexid is formed. On evaporating the same with nitric acid of a specific gravity of 1.4 a pale-yellow residue is left, which, on being heated with potash lye (KHO solution) gives an intensely orange-colored solution.
S-methylxanthin has no melting-point. At substantially 380 centigrade it begins to turn brown, and at a temperature above 400 centigrade it is decomposed.
The above reaction of acetic-acid anhydride or uric acid may be accomplished in a briefer period of time than stated above if the reagents are caused to act upon each other either under pressu ree. g. in a digester-or in the presence of a condensing agent. For example, if one part of uric acid proper is heated together with from five to six parts acetic acid in a closed vessel, such as an autoclave, while constantly stirring or agitating the mass, to a temperature of 180 centigrade and maintained; at this temperature for twentyfour hours theconversion into 8-methylxanthin will be completed. After cooling a considerable pressure exists in the autoclave, while the methylxanthin will be obtained in the form of a rather brown powder, which may be isolated and purified in the manner above given. The same acceleration of the reaction may be obtained when a condensing agent is added to the mixture of uric acid proper and acetic-acid anhydride. Thus, for example, I may add 0.5 parts of pyridin to one part of uric acid proper and ten parts of acetic anhydride. Under these conditions the formation of S-methylxanthin will have been accomplished after the boiling for from forty to forty-five hours in a reflux apparatus. The new product is thereby obtain ed in a very pure condition and may be isolated in the manner above given.
2. Preparation f 3 8 dimethyZma'n-ihtn from E-meflryZ-urz'c acid-One part of 3;
methyl-uric acid, which is identical with 8 methyl-uric acid, as describede. g., in Berichte der Deuischen Ohemischen Gesellschafl, Vol. 32,page 2726is heated to ebullition with ten parts of acetic-acid anhydride in a reflux cooler and with the addition of 0.5 parts pyridin. The conversion into the corresponding xanthin takes place without apparent solution of the methyl-uric acid. After the lapse of about forty hours continued boiling the difficultly-solubleproduct ceases to red uce ammoniacal silver solution. The whole is thereupon allowed to cool and the liquid is drained from the resultant slightly-colored granular powder by filtration, and the same is then crystallized from boiling water having animal charcoal added thereto for decolorizing purposes. The new body 3-8-dimethylxanthin is thus obtained in the form of fine colorless crystals in the form of needles which are matted or felted asbestos-like and which contain one molecule of water of crystallization. This water escapes at 110 oentigrade. Analysis of the compound thus dried yields figures, which show its composition to be O H N O Its structural formula is:
HNOO
H 00 o N o.cH oH,.N-c-N The addition of the methyl radical to the carbon-atom 8 greatly enhances the solubility of the 3-methylxanthin in water. W'hile 3-methylxanthin requires three hundred and fifty parts of boiling water for complete solution, (Berliner Berichte, Vol. 31, page 1986,) 3-8-dimethylxanthin requires only seventy five parts of boiling water and crystallizes from such solution in the form of fine colorless needles matted together like asbestos and containing one molecule of water of crystallization.
3-8-dimethylxanthin is readily soluble in dilute alkalies, including ammonia. When concentrated soda-lye (NaHO solution) is added, a sodium salt of the same, which crystallizes in fine needles, is soon separated from the whole. Dilute mineral acids readily take.
up S-S-methylxanthin on heating. From a solution of the same in dilute nitric acid a double salt, crystallizing in fine needles, is thrown out by nitrate of silver. 011 adding silver nitrate to an aminoniacal solution of the same a colorless gelatinous silver salt is thrown out, which remains unchanged on boiling.
3-8-dimethylxanthin assumes a brownish color on being heated to above 320 centigrade, and at about 350 centi grade it melts with decomposition.
3. Preparation of l-3-8-irimethylmanihm from 1-3-dimcthyl-uric acid.-One part. of
l-3-dimethyl-uric acid free from water is heated with ten parts of acetic anhydride and O. 5 parts pyridin in a reflux apparatus to boiling temperature. The dimethyluric acid will thereby be gradually dissolved. After boiling the mixture for twenty hours the formation of the new xanthin will be accomplished. The prod uct,which on cooling crystallizes from the clear anhydride solution, is not reducible by a silver solutiona fact whichindicatestheendofthe reaction. From the trimethylxanthin which separates in the form of fine needles the mother-liquor is drained by siphoning or any desired method, and the residual trimethylxanthin is then purified by dissolving in boiling Water or alcohol and recrystallizing from such solution. The resultant fine acicular or prismatic crystals, for the most part aggregated in the form of fagots, contain no water of crystallization. The product when dried at 120 ceutigrade and analyzed gives figures from which the formula of the same is ascertained to be O H N O Its structural formular is:
The reaction to which its formation is due is indicated in the equation:
This new trimethylxanthin is soluble in about forty parts of boiling water. Hence by the formation of this body the solubility of 1-3- dimethylxanthin, which is the same as theophyllin and which requires only eight parts of water for solution, (see Bert'chie, Vol. 28, page 3189,) has been very materially reduced by the S-methyl. 1-3-8-trimethylxanthin is rather soluble in boiling alcohol and moderately so in boiling chloroform. Moreover, it is readily soluble in ammonia and dilute alkalies. From concentrated alkali solutions the corresponding alkali salts are immediately thrown out in the form of fine acicular crystals. It is readily soluble in dilute mineral acids. With nitrate of silver in nitric-acid solution a double salt, crystallizing in fine needles, is formed. An ammoniacal solution of the same forms with nitrate of silver a silver salt, which is very difficultly soluble in ammonia and which is perfectly stable when boiling.
1-3-8-trimethylxanthin melts to a pale-colored liquid at 325 centigrade and sublimes almost without decomposition when continuously heated to a higher temperature in the form of fine colorless needles.
4. Preparation of 8-ethyl wanthin from uric acid pr0per.0ne part of uric acid proper is heated to boiling temperature, together with ten parts of propionic-acid anhydride and 0.5 parts of pyridin in a reflux apparatus. After boiling for twenty hours the conversion of the uric acid into S-ethylxanthin will be completeda stage of the process which is indicated by the fact that the product which remains undissolved in the anhydrid ceases to reduce an ammoniacal silver solution. The resultant slightly-colored crystalline powder is dissolved in dilute alkali and treated with carbon (such as animal carbon or bone-black) for the purposes of decoloration. From such solution the 8-ethylxanthin is precipitated by dilute acids as a colorless fine granular powder, whose analysis gives figures corresponding to the formula C H N O or, structurally,
The reaction to which the formation of this new compound is due proceeds according to the equation:
HN-CO oo. OH GH,
I I H 00 O-N O 00 HN O-NH 0. CH CH (Uric acid.) (Propiom'c anhydride.)
1 'ce'igesi HN-GO soluble in alkalies, including ammonia,and on heating also in dilute acids. A solution of the same gives rise to a colorless gelatinous silver salt when nitrate of silver is added thereto,said silver salt being soluble only with difficulty in excess of ammonia and remaining unchanged on boiling. If the new base be dissolved in dilute nitric acid and silver nitrate be added to such solution, a colorless double salt, which crystallizes in fine needles, is precipitated.
S-ethylxanthin on being heated above 350 centigrade assumes a brownish color, and at about 390 centigrade it is decomposed with effervescence or frothing.
5. Preparation of 8-t'sopropylxanthin from uric acid proper.0ne part of uric acid, together with six parts of isobutyric acid anhydride and 0.4 parts of pyridin are heated to 170 to 175 centigrade in a closed tube and maintained at this temperature for thirty-six hours, the mass being continuously agitated during this treatment. On thereafter allowing the mass to cool strong pressure will exist in the tube, and the almost colorless resultant undissolved product will not reduce a silver solution on boiling. The liquor is then drained from the solid product, and the latter is dissolved in dilute alkali and treated with carbon in the ordinary manner and acidulated with a dilute mineral acid. Thereby a colorless powder, consisting of compact granular crystals, is obtained, which on analysis has been found to have the formula G H N O or, structurally expressed,
The formation of the S-isopropylxanthin under the above reaction proceeds according to the equation:
o H HN-GH o-owa OIJLN (Uric acid.) (Isobutyric acid anhydride.)
N l l H o o u +oo,+ cH .,),.oH.oooH c.cn cn I-IN-G-N (S-isopropylxanthin.)
(Isobutyric acid.)
340 centi grade it assumes a gold-brown color,
and at about 380 centigrade it melts with effervescence or frothing.
Having thus fully described my invention, what I claim as new, and desire to secure by Letters Patent, is
1. The process of preparing Xanthin homolognes, which consists in heating a uric acid together with an organic-acid anhydride.
2. The process of preparing Xanthin homologues, which consists in heating a uric acid together with an organic-acid anliydride under pressure.
3. The process of preparing Xanthin homologues, which consists in heating a uric acid together with an organic-acid anhydride and a condensing agent.
4. The process of preparing xanthin homologues, which consists in heating a uric acid together with an organic-acid anhydride and a condensing agent under pressure.
5. The process of preparing an 8-alkylxanthin which consists in heating uric acid proper together with an organic-acid anhydride.
6. The process of preparing an 8-alkyl- Xanthin which consists in heating under pressure uric acid proper together with an organicacid anhydride.
- 7. The process of preparing an 8-alkylxanthin which consists in heating uric acid proper together with organic-acid anhydride and a condensing agent.
8. The process of preparing an S-alkyl- Xanthin which consists in heating under pressure uric acid proper and an organic-acid anhydride together with a condensing agent.
9. The process of preparing an S-alkylxanthin which consists in heating a uric acid and an organic-acid anhydride together with pyridin.
10. The process of preparing an S-alkyl- Xanthin which consists in heating under pressure a uric acid and an organic-acid anhydride together with pyridin.
11. As a new chemical compound,a homologue of xanthin having an alkyl radical bound to the position 8, and having the properties of Xanthin proper.
12. As a new chemical compound, 8-alkylxanthin whose formula differs from that of Xanthin proper by having an alkyl radical substituted for the H in the position 8, which is readily soluble in alkalies including ammonia, and in dilute acids and difficultly soluble in boiling water, which is precipitated from the alkaline solution by dilute acids in the form of a granular powder, which becomes colored on heating to a high .temperature and which has no melting-point but decomposes wit-h frothing on heating to a still higher temperature. I
In testimony whereof I aflix my signature in presence of two witnesses.
' FRITZ AOH. Witnesses:
J. ADRIAN, MAX BONHUER.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2403100A US667381A (en) | 1900-07-18 | 1900-07-18 | Xanthin homologue and process of making same. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2403100A US667381A (en) | 1900-07-18 | 1900-07-18 | Xanthin homologue and process of making same. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US667381A true US667381A (en) | 1901-02-05 |
Family
ID=2735937
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US2403100A Expired - Lifetime US667381A (en) | 1900-07-18 | 1900-07-18 | Xanthin homologue and process of making same. |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US667381A (en) |
-
1900
- 1900-07-18 US US2403100A patent/US667381A/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO146541B (en) | PROCEDURE FOR PREPARING SOFT ETHYLENIC POLYMER RESIN FOAM | |
| US2436659A (en) | Process of making d-saccharic acid | |
| Herring et al. | Catalyzed nitration of amines: I. dinitroxydiethylnitramine | |
| US667381A (en) | Xanthin homologue and process of making same. | |
| US2569288A (en) | Preparation of n-benzyl-betahalopropionamides | |
| SU685156A3 (en) | Method of obtaining n-(5-tetrazolyl)-1-oxo-1h-pyramido-(1,2-a)-quinolin-2-carboxamide | |
| JONES et al. | ADENINE MONONUCLEOTIDE¹ | |
| US631760A (en) | Alkylized xanthin and process of making same. | |
| US726126A (en) | Mercury salts of ethylenediamin bases and process of making same. | |
| US654120A (en) | Alkyloxychloropurin and method of preparing same. | |
| US707812A (en) | Alkoxy-caffein and process of making same. | |
| US617985A (en) | Emil fischer | |
| US631759A (en) | Alkyl-xanthin and process of making same. | |
| US607028A (en) | Emil fischer | |
| US616700A (en) | Emil fischer | |
| US654123A (en) | Formic aldehyde compound of uric acid and process of making same. | |
| US631762A (en) | Process of making oxymethylene-uric acid. | |
| US1161866A (en) | Compound of silver glycocholate readily soluble in water. | |
| US631705A (en) | Process of making theobromin. | |
| US631761A (en) | Process of preparing alkyl-uric acid. | |
| US2748120A (en) | 2-amino-6-aryl-5, 6-dihydro-4-hydroxy-pyrimidines | |
| US2495246A (en) | Method of preparing sodium 1-ascorbate | |
| US708513A (en) | Thioxanthin and process of making same. | |
| US676860A (en) | ParaƤmidophenyl-glyoxylic acid and process of making same. | |
| US2654753A (en) | 2-sulfanilamido-5-aminopyrimidine and salts thereof |